Haleon PLC (NYSE: HLN) witnessed a pre-market surge of 5.11% on Friday, driven by the company's positive earnings report and optimistic outlook for the year ahead. The stock's rally reflects investor confidence in Haleon's growth strategies, particularly in emerging markets and its robust oral health division.

In its Q4 2024 earnings call, Haleon highlighted strong momentum in key emerging markets such as India and China, which contributed significantly to the company's overall growth. Additionally, the oral health division has been performing exceptionally well, with plans for further expansion in distribution and geographical rollout, supported by a strong innovation pipeline.

Haleon expressed confidence in achieving 4% to 6% growth for the full year, underpinned by its market expansion strategies and continued focus on innovation. The company has also increased its advertising and promotional (A&P) investment by 10.2% to support growth initiatives, including enhanced expert coverage and sampling efforts.